These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2588953

  • 1. Transfer of the adenosine deaminase (ADA) gene of a B-lymphoblastoid cell line (LCL) to an ADA-deficient LCL by a microcell-mediated chromosome transfer technique.
    Sawami H, Ito K, Norioka M, Monden S, Fujita M, Uchino H.
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1033-44. PubMed ID: 2588953
    [Abstract] [Full Text] [Related]

  • 2. Comparative characterization of B-lymphoblastoid cell lines in adenosine deaminase deficiency and its heterozygote.
    Sawami H, Toyokawa Y, Ito K, Uchino H.
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):721-9. PubMed ID: 2618547
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Normal and mutant human adenosine deaminase genes.
    Akeson AL, Wiginton DA, Hutton JJ.
    J Cell Biochem; 1989 Mar; 39(3):217-28. PubMed ID: 2651461
    [Abstract] [Full Text] [Related]

  • 5. Characterization of an adenosine deaminase-deficient human histiocytic lymphoma cell line (DHL-9) and selection of mutants deficient in adenosir kinase and deoxycytidine kinase.
    Kubota M, Kamatani N, Daddona PE, Carson DA.
    Cancer Res; 1983 Jun; 43(6):2606-10. PubMed ID: 6303563
    [Abstract] [Full Text] [Related]

  • 6. Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer.
    Belmont JW, Henkel-Tigges J, Chang SM, Wager-Smith K, Kellems RE, Dick JE, Magli MC, Phillips RA, Bernstein A, Caskey CT.
    Nature; 1983 Jun; 322(6077):385-7. PubMed ID: 3016551
    [Abstract] [Full Text] [Related]

  • 7. An approach to a selection system for adenosine-deaminase-positive (ADA+) cells and detection of rat ADA+ "revertants".
    Hirschhorn R, Ellenbogen A, Martiniuk F.
    J Cell Physiol; 1985 May; 123(2):277-82. PubMed ID: 3872305
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Somatic cell genetics of adenosine deaminase expression and severe combined immunodeficiency disease in humans.
    Koch G, Shows TB.
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4211-5. PubMed ID: 6933468
    [Abstract] [Full Text] [Related]

  • 10. Bone marrow gene therapy for adenosine deaminase deficiency.
    Kaptein LC, Einerhand MP, Braakman E, Valerio D, van Beusechem VW.
    Immunodeficiency; 1993 Jul; 4(1-4):335-45. PubMed ID: 7909479
    [Abstract] [Full Text] [Related]

  • 11. Multiple chromosomes carrying tumor suppressor activity for a uterine endometrial carcinoma cell line identified by microcell-mediated chromosome transfer.
    Yamada H, Wake N, Fujimoto S, Barrett JC, Oshimura M.
    Oncogene; 1990 Aug; 5(8):1141-7. PubMed ID: 2392323
    [Abstract] [Full Text] [Related]

  • 12. Localization of human adenosine deaminase (ADA) gene sequences to the q12----q13.11 region of chromosome 20 by in situ hybridization.
    Jhanwar SC, Berkvens TM, Breukel C, van Ormondt H, van der Eb AJ, Meera Khan P.
    Cytogenet Cell Genet; 1989 Aug; 50(2-3):168-71. PubMed ID: 2776485
    [Abstract] [Full Text] [Related]

  • 13. Adenosine deaminase deficiency due to heterozygous abnormality consisting of a deletion of exon 7 and the absence of enzyme mRNA.
    Kashii S, Ito K, Monden S, Sasai Y, Tsuchida K, Fujita M, Kawamoto H, Norioka M, Okuma M.
    J Cell Biochem; 1991 Sep; 47(1):49-53. PubMed ID: 1939366
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiency.
    Markert ML, Hershfield MS, Wiginton DA, States JC, Ward FE, Bigner SH, Buckley RH, Kaufman RE, Hutton JJ.
    J Immunol; 1987 May 15; 138(10):3203-6. PubMed ID: 3571974
    [Abstract] [Full Text] [Related]

  • 16. Visible integration of the adenosine deaminase (ADA) gene into the recipient genome after gene therapy.
    Egashira M, Ariga T, Kawamura N, Miyoshi O, Niikawa N, Sakiyama Y.
    Am J Med Genet; 1998 Jan 23; 75(3):314-7. PubMed ID: 9475605
    [Abstract] [Full Text] [Related]

  • 17. [Genetic and epigenetic control of adenosine deaminase expression. Analysis of human and man-mouse hybrid cells (author's transl)].
    Nguyen VC, Weil D, Gross MS, Foubert C, Jami J, Frézal J.
    Ann Genet; 1981 Jan 23; 24(3):141-7. PubMed ID: 6974523
    [Abstract] [Full Text] [Related]

  • 18. In vivo kinetics of transduced cells in peripheral T cell-directed gene therapy: role of CD8+ cells in improved immunological function in an adenosine deaminase (ADA)-SCID patient.
    Kawamura N, Ariga T, Ohtsu M, Kobayashi I, Yamada M, Tame A, Furuta H, Okano M, Egashira M, Niikawa N, Kobayashi K, Sakiyama Y.
    J Immunol; 1999 Aug 15; 163(4):2256-61. PubMed ID: 10438969
    [Abstract] [Full Text] [Related]

  • 19. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
    Hirschhorn R, Roegner V, Jenkins T, Seaman C, Piomelli S, Borkowsky W.
    J Clin Invest; 1979 Oct 15; 64(4):1130-9. PubMed ID: 479373
    [Abstract] [Full Text] [Related]

  • 20. Basic defect in the expression of adenosine deaminase in ADA-SCID disease. II. Deficiency of ADA-CRM detected in heterozygote human-Chinese hamster cell hybrids.
    Herbschleb-Voogt E, Scholten JW, Meera Khan P.
    Hum Genet; 1983 Oct 15; 63(2):121-5. PubMed ID: 6840756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.